期刊文献+

延续性护理在膀胱癌术后膀胱灌注化疗中的应用研究 被引量:6

Continuous nursing in bladder cancer after bladder chemotherapy
下载PDF
导出
摘要 目的探讨延续性护理在膀胱癌术后膀胱灌注化疗中的应用效果。方法将2015年11月—2016年11月期间来我院就诊的60例膀胱癌患者随机分为2组,常规护理组30例实行常规护理,延续护理组30例实行延续性护理,对比分析2组患者治疗依从性、并发症发生率以及复发率。结果延续护理组患者治疗依从性明显高于常规护理组,并发症以及复发率明显低于常规护理组,差异均有统计学意义(P<0.05)。结论对膀胱癌术后膀胱灌注化疗患者实行延续性护理可有效提升患者治疗依从性,降低并发症发生率和复发率,值得临床推广应用。 Objective To investigate the clinical effect of continuous nursing in bladder cancer after bladder cancerchemotherapy. Methods Sixty patients with bladder cancer who came to our hospital from November 2015 to November2016 were randomly divided into continuous nursing group and routine nursing group, while 30 patients in routine nursinggroup underwent routine nursing. Sex care, after the experiment, comparative analysis of two groups of patients compliance,complications and recurrence rate.Results By contrast, the follow-up nursing group patients compliance was significantlyhigher than the conventional care group, complications and recurrence rate was significantly lower than the conventional caregroup, P〈0.05.Conclusion The continuous nursing of patients with bladder cancer after bladder irrigation chemotherapycan effectively improve the compliance of patients' treatment and reduce the complication and recurrence rate, which isworthy of clinical application.
机构地区 玉山县人民医院
出处 《基层医学论坛》 2017年第36期5059-5060,共2页 The Medical Forum
基金 上饶市科技计划指导项目(20163CZD18)
关键词 膀胱癌 膀胱灌注化疗 延续性护理 应用效果 Bladder cancer Intravesical chemotherapy Continuous nursing Clinical curative effect
  • 相关文献

参考文献6

二级参考文献77

  • 1刘蕾,杨晓霞,曾婕,高艳,刘曼.延续护理对慢性阻塞性肺疾病出院患者的干预效果[J].中国老年学杂志,2014,34(12):3333-3335. 被引量:51
  • 2张杰敏,阮萍,谢庆环,邢立花,卢金凤.膀胱灌注药物预防膀胱癌术后复发的护理[J].护理研究(下旬版),2005,19(9):1955-1956. 被引量:8
  • 3Palapattu GS, Bastian PJ, Slavney PH, et al. Preoperative so- matic symptoms are associated with disease progression in patients with bladder carcinoma after cystectomy [ J ]. Canc- er,2004 ( 101 ) :2209 - 2213.
  • 4张秋玉.膀胱癌术后膀胱灌注患者的心理状况调查及护理干预[J].泰山医学院学报,2007,28(3):217-219. 被引量:11
  • 5唐梅.膀胱肿瘤术后行吡柔比星膀胱灌注的护理干预[J].医药前沿,2012(33):234.
  • 6Jiang S J, Ye LY, Meng FH. Comparison of intravesical bacillus Calmette-Guerin and mitomycin C administration for non-muscle in- vasive bladder eancer:A meta-analysisand systematic review[ J]. On- col Lett,2016,11 (4) :2751-2756.
  • 7Packiam VT, Pearce SM, Steinberg GD. The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Gu6rin failures for non-muscle-invasive bladder cancer [ J]. Ther Adv Urol, 2016,8 ( 1 ) :29-37.
  • 8Garafalo L. Continuing Nursing Education and Outcomes: Making a Difference in Patient Care [ J ]. J Contin Educ Nuts, 2016,47 ( 3 ) : 103-105.
  • 9Carvalho DR. Improving Access to Adjuvant Intravesical Therapy for Non-Muscle Invasive Bladder Cancer in a Community Hospital [ J ]. Urol Nurs,2015,35 (6) :287-291.
  • 10Steinberg RL, Thomas LJ, Nepple KG. Intravesical and alternativeblad- der-preservation therapies in the management of non-muscle-invasive bladder cancer unresponsive to bacillus Calmette-Gurin[ J]. Urol 0n- col,2016,34(6) :279-289.

共引文献68

同被引文献39

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部